PATHWAY THERAPY AND CONSULTANCY SERVICES LTD

Executive Summary

PATHWAY THERAPY AND CONSULTANCY SERVICES LTD exhibits significant solvency and liquidity risks, with negative net assets and cash balances shortly after incorporation. While compliance with statutory filings is maintained, the business’s operational viability remains uncertain given minimal financial history and negative working capital. Further investigation into cash flow, related-party transactions, and future business prospects is essential before considering investment exposure.

PATHWAY THERAPY AND CONSULTANCY SERVICES LTD - Analysis Report

Company Number: 15145292

Analysis Date: 2025-07-20 17:38 UTC

1. Risk Rating: HIGH
   The company's financial position at the latest year-end shows net liabilities of £824, negative cash balances, and negative shareholders’ funds. This indicates an immediate solvency concern. The company is newly incorporated with limited operational history and a single employee, which raises concerns over operational stability.

2. Key Concerns:

• Negative net assets and shareholders’ funds (£-824) reflect insolvency at the balance sheet date.
• Negative cash at bank (£-825) signals liquidity difficulties and inability to meet short-term obligations.
• Very limited operating history since incorporation in September 2023 and minimal financial data limit confidence in business sustainability.

3. Positive Indicators:

• The company is compliant with filing deadlines; no overdue accounts or confirmation statements.
• Change of control and director appointments appear transparent and timely.
• The business operates in management consultancy (SIC 70229), a sector with relatively low capital intensity.

4. Due Diligence Notes:

• Investigate the nature of the negative cash figure and whether it reflects an overdraft facility or accounting treatment.
• Clarify the source of negative equity and whether there are contingent liabilities or unpaid debts to related parties.
• Review the business plan, contracts, and pipeline to assess viability and ability to generate positive cash flows.
• Confirm no director disqualifications or regulatory compliance issues beyond available data.
• Assess related-party transactions given the director and PSC overlap and the director’s account debtor balance.